ABERNETHY MATT 4
4 · FATE THERAPEUTICS INC · Filed May 30, 2025
Insider Transaction Report
Form 4
ABERNETHY MATT
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-05-29+110,000→ 110,000 totalExercise: $1.32Exp: 2035-05-28→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in 36 equal monthly installments following May 29, 2025, such that all of the shares shall be fully vested and exercisable on May 29, 2028, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date.